ANA Annual Meeting

PHILADELPHIA — Patients who availed themselves of specialized care for neurofibromatosis received more guideline-concordant care than other patients, with differences found along racial and economic lines, per a poster presentation.

PHILADELPHIA — In older adults, the presence of white and gray matter abnormalities on MRI is linked to greater risk for late-onset epilepsy, according to a poster presentation.

PHILADELPHIA — Language training, communication among patients, caregivers and clinicians, and limited treatment wait times are needed for those with limited language proficiency to receive required neurological care, according to a poster.

PHILADELPHIA — Ensuring underrepresented populations come to the forefront of academic and clinical concerns in the field of neurology is key to advancing the specialty, according to a speaker at the American Neurological Association annual meeting.

PHILADELPHIA — A machine learning model was better able to predict preclinical Alzheimer’s disease from participant biomarkers as well as driving data from a year-long study, according to a speaker.

PHILADELPHIA — Tracking to chart various eye movements including saccadic and fixation may be effective in differentiating neurological differences between children with ASD and neurotypical children, according to a poster presentation.

PHILADELPHIA — For those with aphasia, treatment with transcranial direct current stimulation resulted in speech improvement as early as 1 week, with significant results at 5 weeks compared with sham, according to research.

PHILADELPHIA — In order for underserved communities to successfully engage in clinical research, clear communication and multidisciplinary outreach by the medical community is necessary, according to a speaker.

PHILADELPHIA — Individuals who sustained a head injury had a 34% higher risk for suffering ischemic stroke than those who did not have a head injury, according to an expert at the American Neurological Association annual meeting.

PHILADELPHIA — Consideration of multiple factors among patients, families and health care providers drive the process of diagnosing preclinical or prodromal neurologic disease, which should be tailored to the individual, a speaker said.